Participating in Alzheimer's Research
Scientists are making great strides in identifying potential new interventions to diagnose, slow, prevent, treat, and someday cure Alzheimer's disease. Currently, more than 90 drugs are in clinical trials for AD, and more are in the pipeline awaiting Food and Drug Administration (FDA) approval to enter human testing.
AD research can move forward only if people are willing to volunteer for trials and studies. Before any new drug or therapy can used in clinical practice, it must be rigorously tested in humans to find out whether it is safe and effective. Today, at least 50,000 volunteers both with and without Alzheimer’s are urgently needed to participate in more than 175 actively enrolling Alzheimer’s disease clinical trials and studies in the U.S. To reach that goal, researchers will have to screen at least half a million potential volunteers.
Find a Trial or Study
To find clinical trials and studies on Alzheimer's disease and dementia currently in progress at centers throughout the U.S., go to the ADEAR Clinical Trials Database or call the ADEAR Center at 1-800-438-4380.
You may also wish to visit these clinical trials websites:
For More Information
Related Videos
The Pulse of Drug Development (15 mins)
How Far We Have Come in Alzheimer's Research (15 mins)
Searching for an Alzheimer's Cure: The Story of Flurizan (30 mins)
Participating in Research: A Legacy of Hope (13 mins)
NIA-Funded AD Research Centers and Studies
